RU2759600C2 - Применение каротиноида микробного происхождения, влияющего на состав микроорганизмов кишечника - Google Patents

Применение каротиноида микробного происхождения, влияющего на состав микроорганизмов кишечника Download PDF

Info

Publication number
RU2759600C2
RU2759600C2 RU2019101481A RU2019101481A RU2759600C2 RU 2759600 C2 RU2759600 C2 RU 2759600C2 RU 2019101481 A RU2019101481 A RU 2019101481A RU 2019101481 A RU2019101481 A RU 2019101481A RU 2759600 C2 RU2759600 C2 RU 2759600C2
Authority
RU
Russia
Prior art keywords
carotenoids
intestinal
strain
carotenoid
microbial
Prior art date
Application number
RU2019101481A
Other languages
English (en)
Russian (ru)
Other versions
RU2019101481A3 (enExample
RU2019101481A (ru
Inventor
Сэм ПОССЕМИРС
Синди ДЁЙСБЮРГ
Ирис ПИНЕЙРО
Селин БОЛКА
Питер ВАН ДЕН АББЕЛЕ
Массимо МАРЦОРАТИ
Original Assignee
Майкробиал Рисерч Менеджмент Хелс НВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Майкробиал Рисерч Менеджмент Хелс НВ filed Critical Майкробиал Рисерч Менеджмент Хелс НВ
Publication of RU2019101481A publication Critical patent/RU2019101481A/ru
Publication of RU2019101481A3 publication Critical patent/RU2019101481A3/ru
Application granted granted Critical
Publication of RU2759600C2 publication Critical patent/RU2759600C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
RU2019101481A 2016-06-22 2017-06-22 Применение каротиноида микробного происхождения, влияющего на состав микроорганизмов кишечника RU2759600C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16175832.1 2016-06-22
EP16175832 2016-06-22
PCT/EP2017/065348 WO2017220708A1 (en) 2016-06-22 2017-06-22 Microbial carotenoids affecting gut microbial composition

Publications (3)

Publication Number Publication Date
RU2019101481A RU2019101481A (ru) 2020-07-22
RU2019101481A3 RU2019101481A3 (enExample) 2020-10-16
RU2759600C2 true RU2759600C2 (ru) 2021-11-16

Family

ID=56203217

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019101481A RU2759600C2 (ru) 2016-06-22 2017-06-22 Применение каротиноида микробного происхождения, влияющего на состав микроорганизмов кишечника

Country Status (12)

Country Link
US (1) US11324717B2 (enExample)
EP (1) EP3474862B1 (enExample)
JP (1) JP6966543B2 (enExample)
KR (1) KR102413408B1 (enExample)
CN (1) CN109641006B (enExample)
AU (1) AU2017281589B2 (enExample)
BR (1) BR112018076485A8 (enExample)
CA (1) CA3028031C (enExample)
IL (1) IL263683B (enExample)
MX (1) MX390386B (enExample)
RU (1) RU2759600C2 (enExample)
WO (1) WO2017220708A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114949001A (zh) 2012-08-29 2022-08-30 加州理工学院 孤独症谱系障碍的诊断和治疗
US10124025B2 (en) 2014-10-30 2018-11-13 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
KR20170086492A (ko) 2014-10-30 2017-07-26 캘리포니아 인스티튜트 오브 테크놀로지 신경발달 장애에서의 행동을 개선시키기 위한 박테리아를 포함하는 조성물 및 방법
KR20190127710A (ko) * 2017-02-07 2019-11-13 캘리포니아 인스티튜트 오브 테크놀로지 헌팅톤병 및 레트 증후군에서의 장 미생물총의 조정
MX2020005875A (es) 2017-12-05 2020-10-08 Bioplx Inc Métodos y composiciones para prevenir la infección microbiana.
WO2020043797A1 (en) * 2018-08-29 2020-03-05 Dsm Ip Assets B.V. Formulations for improving gut health
CN110283754B (zh) * 2019-07-11 2021-02-02 中国科学院北京基因组研究所 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群
KR102369996B1 (ko) * 2020-04-21 2022-03-02 박선민 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법
CN115606802A (zh) * 2022-10-21 2023-01-17 中国农业大学 番茄红素在制备修复肠屏障损伤的产品中的应用
WO2025262090A1 (en) 2024-06-18 2025-12-26 Dsm Ip Assets B.V. Combination of carotenoids and inulin and uses thereof
CN119184223A (zh) * 2024-10-14 2024-12-27 元医(杭州)科技有限公司 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066108A1 (en) * 2005-12-06 2007-06-14 Royal Holloway And Bedford New College Bacterial production of carotenoids
RU2433823C2 (ru) * 2005-01-31 2011-11-20 Милан Лэборетериз, Инк. Фармацевтическая композиция, содержащая гидроксилированный небиволол
WO2012017199A1 (en) * 2010-08-03 2012-02-09 Royal Holloway And Bedford New College Et Al Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2433823C2 (ru) * 2005-01-31 2011-11-20 Милан Лэборетериз, Инк. Фармацевтическая композиция, содержащая гидроксилированный небиволол
WO2007066108A1 (en) * 2005-12-06 2007-06-14 Royal Holloway And Bedford New College Bacterial production of carotenoids
WO2012017199A1 (en) * 2010-08-03 2012-02-09 Royal Holloway And Bedford New College Et Al Fatty acid esters of carotenoid glucosides as colouring agents for foodstuffs

Also Published As

Publication number Publication date
RU2019101481A3 (enExample) 2020-10-16
BR112018076485A2 (pt) 2019-04-09
JP2019524877A (ja) 2019-09-05
IL263683B (en) 2022-04-01
KR20190039687A (ko) 2019-04-15
US20190209516A1 (en) 2019-07-11
US11324717B2 (en) 2022-05-10
KR102413408B1 (ko) 2022-06-27
BR112018076485A8 (pt) 2022-12-06
MX2018016118A (es) 2019-07-08
WO2017220708A1 (en) 2017-12-28
CA3028031C (en) 2023-02-28
JP6966543B2 (ja) 2021-11-17
RU2019101481A (ru) 2020-07-22
CN109641006A (zh) 2019-04-16
EP3474862A1 (en) 2019-05-01
CN109641006B (zh) 2022-07-01
AU2017281589A1 (en) 2019-01-31
CA3028031A1 (en) 2017-12-28
MX390386B (es) 2025-03-20
EP3474862B1 (en) 2025-10-29
AU2017281589B2 (en) 2023-03-23
IL263683A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
EP3474862B1 (en) Microbial carotenoids affecting gut microbial composition
Domínguez-Avila et al. Phenolic compounds promote diversity of gut microbiota and maintain colonic health
Leonard et al. Hydroxycinnamic acids on gut microbiota and health
Bomba et al. Improvement of the probiotic effect of micro-organisms by their combination with maltodextrins, fructo-oligosaccharides and polyunsaturated fatty acids
JP6608047B2 (ja) 多様な機能性を有する新規乳酸菌およびその用途
Moharreri et al. Effects of microencapsulated essential oils on growth performance and biomarkers of inflammation in broiler chickens challenged with salmonella enteritidis
Abbasi et al. Postbiotics: science, technology and applications
dos Reis et al. Kefir reduces the incidence of pre-neoplastic lesions in an animal model for colorectal cancer
Wang et al. The effects of dietary ellagic acid supplementation on growth performance, immune response, antioxidant activity, digestive enzyme activities, and intestinal functions in yellow-feathered broilers
Chen et al. Kefir microbiota and metabolites stimulate intestinal mucosal immunity and its early development
JP2019524138A (ja) ラクトバチルス・アシドフィルスを含む更年期の予防または治療用組成物
WO2023066973A1 (en) Probiotic strains for reducing blood cholesterol and/or treating dyslipidemia, and methods for using and producing the same
Odun-Ayo et al. The effect of modified citrus pectin-probiotic on faecal lactobacilli in Balb/c mice
Mateova et al. Effect of probiotics, prebiotics and herb oil on performance and metabolic parameters of broiler chickens
Han et al. Postbiotics ameliorate DSS-induced colitis in mice by regulating gut microbiota, promoting tryptophan metabolism, and activating AhR/IL-22 signaling pathway
Stevens et al. Effect of a carotenoid-producing Bacillus strain on intestinal barrier integrity and systemic delivery of carotenoids: A randomised trial in animals and humans
Li et al. Dietary pectin attenuates Salmonella typhimurium-induced colitis by modulating the TLR2-NF-κB pathway and intestinal microbiota in mice
EP4619019A1 (en) Compositions
Enespa et al. Synbiotics in Nutrition
da FONSECA et al. The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review.
Minuto From youth to old age: therapeutic potential of microbiota interventions in the gut-brain-axis
Borgonovi Biocompostos de buriti e maracujá: perfil, aplicação em leite fermentado probiótico e modulação da microbiota in vitro
WO2025258794A1 (ko) 락토바실러스 파라카제이(lacticaseibacillus paracasei) hy7017를 포함하는 사균체 조성물
Bathal et al. Hypolipidemic activity of probioticated mango and sapota fruit juices in albino Wistar rats.
EA049899B1 (ru) Штаммы бактерий, их композиции и их применение в способах лечения дефицита витамина d и связанных с ним расстройств

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant